FDA hearing on breast cancer drug set for this week

[News]

Genentech, the maker of Avastin, will appeal to the Food and Drug Administration to make its drug available as a treatment for breast cancer — asking for one more chance to prove its efficacy.

More... (http://www.news-medical.net/news/20110628/FDA-hearing-on-breast-cancer-drug-set-for-this-week.aspx)